Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Expert Review of Anticancer Therapy
|
February 6, 2009
mTOR inhibitors for hepatocellular cancer: a forward-moving target
Gerhard Treiber
Journal of Clinical Gastroenterology
|
September 8, 2005
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid
Gerhard Treiber, Peter Malfertheiner
Digestive Diseases (Basel, Switzerland)
|
February 5, 2003
Endoscopy-based research in healthy volunteers
Gerhard Treiber, Peter Malfertheiner
Expert Opinion on Pharmacotherapy
|
February 3, 2007
Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic
Gerhard Treiber, Peter Malfertheiner, Ulrich Klotz
Journal of Gastroenterology and Hepatology
|
August 18, 2005
Determinants of non-response in Helicobacter pylori eradication trials
Ulrich Klotz, Gerhard Treiber, Matthias Schwab
Digestive Diseases (Basel, Switzerland)
|
May 28, 2005
The pathophysiology of portal hypertension
Gerhard Treiber, Antal Csepregi, Peter Malfertheiner
Basic & Clinical Pharmacology & Toxicology
|
July 13, 2004
CYP2C19 polymorphism and proton pump inhibitors
Ulrich Klotz, Matthias Schwab, Gerhard Treiber
Clinical Chemistry and Laboratory Medicine
|
September 11, 2003
A two-step method for the extraction of high-quality RNA from endoscopic biopsies
Thomas Wex, Gerhard Treiber, Uwe Lendeckel, et al.
World Journal of Gastroenterology
|
March 23, 2006
Budesonide induces complete remission in autoimmune hepatitis
Antal Csepregi, Christoph Röcken, Gerhard Treiber, et al.
World Journal of Gastroenterology
|
July 5, 2005
Acute exacerbation of autoimmune hepatitis induced by Twinrix
Antal Csepregi, Gerhard Treiber, Christoph Röcken, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Expert Review of Anticancer Therapy
|
February 6, 2009
mTOR inhibitors for hepatocellular cancer: a forward-moving target
Gerhard Treiber
Journal of Clinical Gastroenterology
|
September 8, 2005
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid
Gerhard Treiber, Peter Malfertheiner
Digestive Diseases (Basel, Switzerland)
|
February 5, 2003
Endoscopy-based research in healthy volunteers
Gerhard Treiber, Peter Malfertheiner
Expert Opinion on Pharmacotherapy
|
February 3, 2007
Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic
Gerhard Treiber, Peter Malfertheiner, Ulrich Klotz
Journal of Gastroenterology and Hepatology
|
August 18, 2005
Determinants of non-response in Helicobacter pylori eradication trials
Ulrich Klotz, Gerhard Treiber, Matthias Schwab
Digestive Diseases (Basel, Switzerland)
|
May 28, 2005
The pathophysiology of portal hypertension
Gerhard Treiber, Antal Csepregi, Peter Malfertheiner
Basic & Clinical Pharmacology & Toxicology
|
July 13, 2004
CYP2C19 polymorphism and proton pump inhibitors
Ulrich Klotz, Matthias Schwab, Gerhard Treiber
Clinical Chemistry and Laboratory Medicine
|
September 11, 2003
A two-step method for the extraction of high-quality RNA from endoscopic biopsies
Thomas Wex, Gerhard Treiber, Uwe Lendeckel, et al.
World Journal of Gastroenterology
|
March 23, 2006
Budesonide induces complete remission in autoimmune hepatitis
Antal Csepregi, Christoph Röcken, Gerhard Treiber, et al.
World Journal of Gastroenterology
|
July 5, 2005
Acute exacerbation of autoimmune hepatitis induced by Twinrix
Antal Csepregi, Gerhard Treiber, Christoph Röcken, et al.
Page
of 4